浓缩丸剂
Search documents
佛慈制药:目前公司产品已出口至美国、加拿大等32个国家和地区
Zheng Quan Ri Bao Zhi Sheng· 2025-08-28 09:07
Group 1 - The company announced on August 28 that its products have been exported to 32 countries and regions, including the United States and Canada, with various dosage forms such as concentrated pills, granules, tablets, and capsules [1] - Since passing the Australian TGA GMP inspection in 1996, the company has become one of the first Chinese traditional medicine enterprises to obtain PIC/S quality system certification and has received multiple international GMP certifications, including from the Australian TGA and Japan's Ministry of Health [1] - The company has achieved a total of 1,442 overseas product registrations and maintains a leading position in the industry regarding the number of foreign certifications, overseas trademark registrations, export coverage, and variety of products [1] Group 2 - The company plans to continue expanding its overseas market presence and deepen international cooperation by leveraging its export advantages through brand building and channel sharing to increase its international market share [1]